Walmart Amlodipine Tablets Recalled for Labeling Error
Legacy Pharmaceutical Packaging is recalling Walmart Amlodipine Besylate Tablets 10 mg due to a label error listing 5 mg in the USP description.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a minor labeling error regarding the declared strength, which fits the rubric for moderate severity.
Plain-English summary
Legacy Pharmaceutical Packaging LLC is recalling 484,236 cartons of Walmart Amlodipine Besylate Tablets, USP 10 mg, Rx only, 30 tablets. The product is manufactured by InvaGen Pharmaceuticals, Inc., manufactured for Camber Pharmaceuticals, Inc., and distributed by Wal-Mart Stores, Inc. The recall covers lots 130251, 130252, and 130253 with an expiration date of 11/14.
The recall was initiated due to a labeling error. The product label contains a misprint in the USP description where 5 mg is listed, although the actual tablet strength is 10 mg. The agency has classified this as a Class II recall.
The affected product was distributed nationwide. Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration date listed above. If the product is found, it should be returned to the pharmacy or point of purchase for a refund or replacement.
The recalled product
- Product
- Walmart Amlodipine Besylate Tablets, USP 10 mg, Rx only, 30 tablets, Manufactured by: InvaGen Pharmaceuticals, Inc., Hauppauge, NY. Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ. Distributed by: Wal-Mart Stores, Inc., Bentonville, AR. Packaged by: Legacy Pharmac
- Manufacturer
- Legacy Pharmaceutical Packaging LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 484,236
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # 130251
- 130252
- 130253 Exp date: 11/14
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Legacy Pharmaceutical Packaging LLC
See all →- HighSertraline Hydrochloride Tablets Recalled Due to Manufacturing Process Defect
FDA (Drugs) · 2024-01-03
- ModerateLegacy Pharmaceutical Recalls Metformin Tablets Due to Foreign Imprint
FDA (Drugs) · 2020-10-07
- SevereLosartan Potassium Tablets Recalled Due to Trace Nitrosamine Impurity
FDA (Drugs) · 2019-05-08
- SevereLosartan Potassium Tablets Recalled Due to Impurity Detection
FDA (Drugs) · 2019-04-10
- SevereLosartan Potassium Tablets Recalled Due to Impurity Detection
FDA (Drugs) · 2019-03-27
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02